This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
Haritaki contains chebulinic acid and chebulagic acid, which act as prebiotics to support beneficial gut bacteria. These compounds provide dose-dependent effects: lower doses (500mg-1g) function as a digestive tonic, while higher doses (3g) promote laxative action. The herb also demonstrates antidiarrheal properties through its astringent action. Evidence level: C. In Tibetan medicine, Haritaki is called the 'king of medicines' for its broad digestive applications.
Does Haritaki interact with any medications?
Haritaki may interact with medications affecting bowel function. Due to its laxative properties at higher doses, it could alter the absorption of oral medications taken at the same time. Those taking antidiarrheal medications should avoid large doses. Limited human drug interaction data exists (Evidence level: C). Consult a healthcare provider before combining with prescription medications, particularly those requiring consistent blood levels or affecting the gastrointestinal tract.
What is the recommended Haritaki dosage for digestion?
For digestive tonic use, adults typically take 500mg to 1g twice daily. For laxative effects, 3g before bed is traditionally recommended. Start with lower doses to assess individual tolerance, as higher amounts may cause loose stools. Evidence level: C. Traditional Ayurvedic practice suggests adjusting the dose based on individual constitution. Always follow product-specific recommendations and consult a qualified practitioner for personalized dosing guidance.
Is Haritaki safe during pregnancy?
Haritaki is generally considered safe during pregnancy at recommended tonic doses (Evidence level: C). However, pregnant women should avoid high doses due to laxative effects that could potentially cause discomfort. Traditional Ayurvedic texts consider it acceptable in moderate amounts. As with any herbal supplement during pregnancy, consult a qualified healthcare provider before use, as individual circumstances and health conditions vary significantly.
Can Haritaki help with constipation?
Yes, Haritaki is traditionally used for constipation relief. At doses of 3g before bed, it acts as a gentle laxative by promoting bowel movement. Unlike harsh stimulant laxatives, Haritaki supports natural bowel regulation and may help with long-term digestive health. Evidence level: C. In Ayurveda, it is considered a bowel regulator, meaning it can address both constipation and diarrhea depending on the dose and individual needs.
Is Haritaki a prebiotic for gut health?
Yes, Haritaki demonstrates prebiotic activity. The active compounds chebulinic acid and chebulagic acid support beneficial gut bacteria, helping maintain healthy microbiome balance. This prebiotic effect contributes to colon health and overall digestive function. Evidence level: C. Traditional use as a digestive tonic aligns with modern understanding of prebiotic benefits. Regular use at tonic doses (500mg-1g twice daily) may support gut microbiome health over time.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Terminalia chebula, commonly known as Haritaki or Myrobalan, is a traditional medicinal plant used across various indigenous systems for its diverse pharmacological activities, including antioxidant and anti-inflammatory effects [PMID:36051270, PMID:28871682].
Background
Terminalia chebula Retz. (Family: Combretaceae) is a tree widely distributed in India and is highly valued in Tibetan, Unani, Tibb, Ayurveda, and Siddha medicine [PMID:24501534, PMID:36051270]. It is often referred to as the 'king' of Mongolian and Tibetan medicines [PMID:28871682].
Traditional uses
Traditionally used to treat ailments such as bleeding, carminative issues, dysentery, liver dysfunction, digestive disorders, diarrhea, analgesic needs, anthelmintic requirements, skin disorders [PMID:36051270], constipation, and diabetes [PMID:27400482]. Folklore uses also include asthma, sore throat, vomiting, hiccough, bleeding piles, ulcers, gout, and heart and bladder diseases [PMID:23620847].
Active compounds
Main chemical components include triterpene acid, galloyl glucose, anthraquinonoid [PMID:28871682], chebulinic acid [PMID:37605424], chebulic acid [PMID:30956868], flavonoids, tannins, and phenolic acids [PMID:32307775].
Mechanism of action
Mechanisms include the regulation of anti-inflammatory factors and suppression of STAT1/3 and NF-κB signaling [PMID:35830757], modulation of Nrf2 and its related enzymes to provide hepatoprotection [PMID:30956868], and inhibition of xanthine oxidase, the uric acid transporter, and NLRP3 inflammasome activation in gout [PMID:40268110]. It also inhibits the TLR4/MyD88/NF-κB axis in hyperuricemic nephropathy [PMID:38159820].
Clinical evidence
Evidence DGastrointestinal Transit
Both Churna and Vati dosage forms significantly shortened intestinal transit time in mice, with Churna being more effective [PMID:23723658].
Evidence DHyperlipidemia/Atherosclerosis
Reduced total cholesterol, triglycerides, and aortic sudanophilia in rabbits and rats [PMID:3225068, PMID:22247850, PMID:22557135].
Evidence DAtopic Dermatitis
Extract ameliorated symptoms in a mouse model by regulating anti-inflammatory factors [PMID:35830757].
Evidence DGout Arthritis
Relieved gout arthritis in rats by inhibiting xanthine oxidase and NLRP3 inflammasome [PMID:40268110].
Evidence DH. pylori Infection
Water extracts showed significant antibacterial activity and inhibited urease activity of H. pylori [PMID:11463533].
Drug interactions
Terminalia chebula has been shown to improve the pharmacologic effects of phenytoin [PMID:37537774].
Evidence summary
The evidence is primarily based on in vitro studies and animal models (Level D), with several comprehensive reviews (Level C) summarizing traditional uses and pharmacological potential. There is a lack of human clinical trial data in the provided abstracts.
PubMed sources
1.PMID: 35830757 (2022) — Terminalia chebula Retz. extract ameliorates the symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1/3 and NF-ĸB signaling in vitro. · Phytomedicine : international journal of phytotherapy and phytopharmacology
2.PMID: 28871682 (2016) — [Pharmacological activity of Terminalia chebula]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
3.PMID: 24501534 (2013) — Haritaki (Chebulic myrobalan) and its varieties. · Ayu
4.PMID: 36051270 (2022) — A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz. · Heliyon
5.PMID: 37605424 (2024) — Chebulinic Acid: An Incipient Anticancer Agent. · Recent patents on anti-cancer drug discovery
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 22557135 (2004) — Hypocholesterolemic effect of Terminalia chebula fruit (Myrobalan) in mice. · Ancient science of life
7.PMID: 27400482 (2016) — Potential therapeutic applications for Terminalia chebula in Iranian traditional medicine. · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
8.PMID: 30956868 (2019) — Protective effects of chebulic acid from Terminalia chebula Retz. against t-BHP-induced oxidative stress by modulations of Nrf2 and its related enzymes in HepG2 cells. · Food science and biotechnology
9.PMID: 22247850 (2010) — Hypolipidemic activity of haritaki (terminalia chebula) in atherogenic diet induced hyperlipidemic rats. · Journal of advanced pharmaceutical technology & research
10.PMID: 37537774 (2023) — Phenytoin's Pharmacological Interactions with Medicinal Herbs: A Review. · Die Pharmazie
11.PMID: 40268110 (2025) — Terminalia chebula Retz. extract relieves gout arthritis by inhibiting xanthine oxidase, the uric acid transporter, and NLRP3 inflammasome activation. · Journal of ethnopharmacology
12.PMID: 11463533 (2001) — Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. · International journal of antimicrobial agents
13.PMID: 23723658 (2012) — A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz]. · Ayu
14.PMID: 23620847 (2013) — The development of Terminalia chebula Retz. (Combretaceae) in clinical research. · Asian Pacific journal of tropical biomedicine
15.PMID: 3225068 (1988) — The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. · International journal of cardiology
16.PMID: 32307775 (2020) — Fruits of Terminalia chebula Retz.: A review on traditional uses, bioactive chemical constituents and pharmacological activities. · Phytotherapy research : PTR
17.PMID: 38159820 (2024) — The Terminalia chebula Retz extract treats hyperuricemic nephropathy by inhibiting TLR4/MyD88/NF-κB axis. · Journal of ethnopharmacology